Primary human T lymphocytes represent an important cell population for adoptive immunotherapies, including chimeric-antigen and T-cell receptor applications, as they have the capability to eliminate non-self, virus-infected and tumor cells. Given the increasing numbers of clinical immunotherapy applications, the development of an optimal vector...
-
2016 (v1)Journal articleUploaded on: December 4, 2022
-
May 2019 (v1)Journal article
International audience
Uploaded on: April 21, 2025 -
February 9, 2021 (v1)Journal article
Baboon Envelope Pseudotyped "Nanoblades" Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34 + Cells and Knock-in of AAV6-Encoded Donor DNA in CD34 + Cells. Front. Genome Ed. 3:604371.
Uploaded on: April 5, 2025 -
February 12, 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
October 2017 (v1)Journal article
Hematopoietic stem cell (HSC)-based gene therapy trials are now moving toward the use of lentiviral vectors (LVs) with success. However, one challenge in the field remains: efficient transduction of HSCs without compromising their stem cell potential. Here we showed that measles virus glycoprotein-displaying LVs (hemagglutinin and fusion...
Uploaded on: December 4, 2022